FDA's AI Elsa, LawZero for AI Safety, and Meta's Ad Automation

In this episode, Bob delves into the FDA's introduction of an AI tool named Elsa designed to streamline drug approvals and discusses its potential impact on the pharmaceutical industry. The conversation then shifts to Yoshua Bengio's new non-profit, LawZero, which aims to enhance AI safety. Bob highlights Google's AI Edge Gallery app, which facilitates the use of offline AI models, potentially broadening AI's reach. The episode also covers Meta's innovative use of AI-driven automation in ad creation, revolutionizing marketing strategies. A sponsor segment is included, followed by Bob's closing thoughts. (0:00) FDA's new AI tool Elsa for drug approvals and its impact (2:24) Yoshua Bengio's non-profit LawZero for AI safety (4:49) Google's AI Edge Gallery app for offline AI models (7:04) Meta's AI-driven automation of ad creation (9:21) Sponsor: ${name}